NCT04673630View on ClinicalTrials.gov

Study to Evaluate the Pharmacokinetics of Tezepelumab in Children With Asthma

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

February 23, 2021

Primary Completion Date

September 27, 2022

Study Completion Date

September 27, 2022

Conditions
Asthma
Interventions
BIOLOGICAL

Tezepelumab

Single dose subcutaneous injection

Trial Locations (6)

1094

Research Site, Budapest

7700

Research Site, Cape Town

BS2 8BJ

Research Site, Bristol

G51 4TF

Research Site, Glasgow

E1 1BB

Research Site, London

SE5 9RS

Research Site, London

Sponsors

Lead Sponsor

AstraZeneca

Collaborators (1)

Amgen
All Listed Sponsors
collaborator

Amgen

INDUSTRY

lead

AstraZeneca

INDUSTRY